Abstract
In this paper the various BBB systems have been described including the various isolation procedures of brain capillary endothelial cells (BCEC), the culture of monolayers of BCEC and endothelial cell lines, and the coculture of BCEC with various types of astrocytes. The transference of results between BBB culture systems has been discussed together with the application of the various BCEC co-culture systems in research. It is concluded that there is a need for interlaboratory validation of BBB data, particularly BBB transport data.
Keywords: Blood-Brain Barrier, BBB Cultures
Current Medicinal Chemistry - Central Nervous System Agents
Title: In Vitro Models of the Blood-Brain Barrier: When to Use Which?
Volume: 2 Issue: 3
Author(s): A(Bert). G. de Boer and P. J. Gaillard
Affiliation:
Keywords: Blood-Brain Barrier, BBB Cultures
Abstract: In this paper the various BBB systems have been described including the various isolation procedures of brain capillary endothelial cells (BCEC), the culture of monolayers of BCEC and endothelial cell lines, and the coculture of BCEC with various types of astrocytes. The transference of results between BBB culture systems has been discussed together with the application of the various BCEC co-culture systems in research. It is concluded that there is a need for interlaboratory validation of BBB data, particularly BBB transport data.
Export Options
About this article
Cite this article as:
de Boer G. A(Bert). and Gaillard J. P., In Vitro Models of the Blood-Brain Barrier: When to Use Which?, Current Medicinal Chemistry - Central Nervous System Agents 2002; 2 (3) . https://dx.doi.org/10.2174/1568015023358012
DOI https://dx.doi.org/10.2174/1568015023358012 |
Print ISSN 1568-0150 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6158 |
Related Articles
-
Isolation, Purification and Characterization of a Novel Steroidal Saponin Cholestanol Glucoside from Lasiodiplodia theobromae that Induces Apoptosis in A549 Cells
Anti-Cancer Agents in Medicinal Chemistry Nucleic Acid-Based Aptamers: Applications, Development and Clinical Trials
Current Medicinal Chemistry Nanotechnology Platforms in Diagnosis and Treatment of Primary Brain Tumors
Recent Patents on Nanotechnology subject Index To Volume 2
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Ion Transporters in Brain Tumors
Current Medicinal Chemistry Current Limitations in the Treatment of Parkinson’s and Alzheimer’s Diseases: State-of-the-Art and Future Perspective of Polymeric Carriers
Current Medicinal Chemistry The Therapeutic Potential of Melatonin in Neurological Disorders
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) microRNA, Cancer and Cancer Chemoprevention
Current Molecular Pharmacology Advances in Photodynamic Therapy Assisted by Electroporation
Current Drug Metabolism Age and Dose-Dependent Effects of Alpha-Lipoic Acid on Human Microtubule- Associated Protein Tau-Induced Endoplasmic Reticulum Unfolded Protein Response: Implications for Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line
Current Drug Delivery The Role of Protein Kinase C-alpha (PKC-α) in Cancer and its Modulation by the Novel PKC-α-Specific Inhibitor Aprinocarsen
Current Pharmaceutical Design Biological Activities of QIAPI 1 as a Melanin Precursor and Its Therapeutic Effects in Wistar Rats Exposed to Arsenic Poisoning
Central Nervous System Agents in Medicinal Chemistry In Vitro Evaluation of Antimicrobial and Antiproliferative Activities for Compounds Isolated from the Ficus Bubu Warb. (Moraceae) Fruits: Chemotaxonomic Significance
Drug Delivery Letters The Role of CD40 Expression in Dendritic Cells in Cancer Biology; A Systematic Review
Current Cancer Drug Targets Small Molecule Complementarity As A Source of Novel Pharmaceutical Agents and Combination Therapies
Current Pharmaceutical Design Current Constructs and Targets in Clinical Development for Antibody- Based Cancer Therapy
Current Drug Targets Reduced Serotonin Transporter Levels and Inflammation in the Midbrain Raphe of 12 Month Old APP<sub>swe</sub>/PSEN<sub>1dE9</sub> Mice
Current Alzheimer Research Druggable Orthosteric and Allosteric Hot Spots to Target Protein-protein Interactions
Current Pharmaceutical Design Modulation of Sensitivity to Antitumor Agents by Targeting the MAPK Survival Pathway
Current Pharmaceutical Design